Cargando…

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era

BACKGROUND: This study presents an analysis of 1,491 serogroup 23 and 762 serogroup 15 isolates from invasive pneumococcal disease (IPD) in children and adults before and after the general recommendation for childhood pneumococcal conjugate vaccination in Germany in July 2006. Vaccination formulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Linden, Mark, Perniciaro, Stephanie, Imöhl, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424534/
https://www.ncbi.nlm.nih.gov/pubmed/25940580
http://dx.doi.org/10.1186/s12879-015-0941-9
_version_ 1782370344497053696
author van der Linden, Mark
Perniciaro, Stephanie
Imöhl, Matthias
author_facet van der Linden, Mark
Perniciaro, Stephanie
Imöhl, Matthias
author_sort van der Linden, Mark
collection PubMed
description BACKGROUND: This study presents an analysis of 1,491 serogroup 23 and 762 serogroup 15 isolates from invasive pneumococcal disease (IPD) in children and adults before and after the general recommendation for childhood pneumococcal conjugate vaccination in Germany in July 2006. Vaccination formulations used were PCV7 (from July 2006), PCV10 (from April 2009) and PCV13 (from December 2009, replacing PCV7). METHODS: The German National Reference Center for Streptococci (GNRCS) has conducted surveillance of IPD since 1992. Isolates were serotyped and tested for antibiotic susceptibility. Selected isolates were characterized using MLST. RESULTS: In an analysis of 23,957 isolates from IPD in children and adults sent to the GNRCS between July 1992 and June 2014, we found a strongly significant increase of non-PCV13 serotypes in the late vaccination (PCV13) period (2010-2014). Among these, the proportions of serotypes 15A and 23B were the most strongly significantly increasing. After the recommendation for pneumococcal conjugate childhood vaccination in 2006 and the introduction of higher-valent vaccines in 2009, the proportion of 15A increased significantly from 0.5% in the early vaccination period (2007-2010) to 2.4% in the late vaccination period (2010-2014, p=3.14x10(-22)). The proportion of serotype 23B increased from 0.5% to 2.8% in the same period (p=1.55x10(-29)). Penicillin non-susceptibility levels of the serotype 15A (47.4%) and serotype 23B (46.5%) isolates were high, with MIC values ranging from 0.12-2 μg/ml (15A) and 0.12-0.5 μg/ml (23B). MLSTs of serotype 23B isolates grouped in two clonal complexes (CC): CC439, with sequence type (ST) 439 as the main representative and CC338 (linked to CC156), with ST1349 as most prevalent clone. Both CCs have been present over almost the whole surveillance period. All penicillin non-susceptible isolates occurred in CC338. Serotype 15A isolates appeared to be more diverse. Six CCs, one group of three STs and two singletons were found among 20 isolates. Most prevalent was CC63, with ST63 as most prominent representative (n=5). Most penicillin non-susceptible isolates were found among CC63 isolates. CONCLUSIONS: The prevalence of non-PCV13 serotypes in Germany has increased significantly between July 2007 and June 2014, with 15A and 23B being the most strongly increasing serotypes of all. Both serotypes show a high proportion of penicillin non-susceptibility.
format Online
Article
Text
id pubmed-4424534
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44245342015-05-09 Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era van der Linden, Mark Perniciaro, Stephanie Imöhl, Matthias BMC Infect Dis Research Article BACKGROUND: This study presents an analysis of 1,491 serogroup 23 and 762 serogroup 15 isolates from invasive pneumococcal disease (IPD) in children and adults before and after the general recommendation for childhood pneumococcal conjugate vaccination in Germany in July 2006. Vaccination formulations used were PCV7 (from July 2006), PCV10 (from April 2009) and PCV13 (from December 2009, replacing PCV7). METHODS: The German National Reference Center for Streptococci (GNRCS) has conducted surveillance of IPD since 1992. Isolates were serotyped and tested for antibiotic susceptibility. Selected isolates were characterized using MLST. RESULTS: In an analysis of 23,957 isolates from IPD in children and adults sent to the GNRCS between July 1992 and June 2014, we found a strongly significant increase of non-PCV13 serotypes in the late vaccination (PCV13) period (2010-2014). Among these, the proportions of serotypes 15A and 23B were the most strongly significantly increasing. After the recommendation for pneumococcal conjugate childhood vaccination in 2006 and the introduction of higher-valent vaccines in 2009, the proportion of 15A increased significantly from 0.5% in the early vaccination period (2007-2010) to 2.4% in the late vaccination period (2010-2014, p=3.14x10(-22)). The proportion of serotype 23B increased from 0.5% to 2.8% in the same period (p=1.55x10(-29)). Penicillin non-susceptibility levels of the serotype 15A (47.4%) and serotype 23B (46.5%) isolates were high, with MIC values ranging from 0.12-2 μg/ml (15A) and 0.12-0.5 μg/ml (23B). MLSTs of serotype 23B isolates grouped in two clonal complexes (CC): CC439, with sequence type (ST) 439 as the main representative and CC338 (linked to CC156), with ST1349 as most prevalent clone. Both CCs have been present over almost the whole surveillance period. All penicillin non-susceptible isolates occurred in CC338. Serotype 15A isolates appeared to be more diverse. Six CCs, one group of three STs and two singletons were found among 20 isolates. Most prevalent was CC63, with ST63 as most prominent representative (n=5). Most penicillin non-susceptible isolates were found among CC63 isolates. CONCLUSIONS: The prevalence of non-PCV13 serotypes in Germany has increased significantly between July 2007 and June 2014, with 15A and 23B being the most strongly increasing serotypes of all. Both serotypes show a high proportion of penicillin non-susceptibility. BioMed Central 2015-05-05 /pmc/articles/PMC4424534/ /pubmed/25940580 http://dx.doi.org/10.1186/s12879-015-0941-9 Text en © van der Linden et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
van der Linden, Mark
Perniciaro, Stephanie
Imöhl, Matthias
Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
title Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
title_full Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
title_fullStr Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
title_full_unstemmed Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
title_short Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
title_sort increase of serotypes 15a and 23b in ipd in germany in the pcv13 vaccination era
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424534/
https://www.ncbi.nlm.nih.gov/pubmed/25940580
http://dx.doi.org/10.1186/s12879-015-0941-9
work_keys_str_mv AT vanderlindenmark increaseofserotypes15aand23binipdingermanyinthepcv13vaccinationera
AT perniciarostephanie increaseofserotypes15aand23binipdingermanyinthepcv13vaccinationera
AT imohlmatthias increaseofserotypes15aand23binipdingermanyinthepcv13vaccinationera